Structure Therapeutics Inc.
GPCR
$23.74
$0.090.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -48.88% | -42.39% | -11.83% | -44.85% | -106.34% |
| Total Depreciation and Amortization | 198.88% | 232.53% | 213.51% | 217.14% | 23.61% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 877.78% | -35.61% | 888.36% | -104.18% | -116.29% |
| Change in Net Operating Assets | -119.63% | 397.75% | -132.99% | -74.82% | 712.84% |
| Cash from Operations | -67.83% | 4.19% | -56.23% | -67.82% | -80.68% |
| Capital Expenditure | 98.62% | 16.46% | -123.56% | -- | -1,528.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 118.51% | -708.61% | -197.85% | 103.22% | -1,824.82% |
| Cash from Investing | 118.39% | -727.45% | -197.65% | 102.89% | -1,847.84% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.80% | -16.07% | 287,772.63% | -99.56% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | -- | -23.74% | 97.96% | -5,750.63% |
| Cash from Financing | -99.78% | -260.04% | 173,400.67% | -99.59% | 89,223.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -103.31% | -2,185.58% | 430.37% | -131.83% | 4,055.82% |